Exosome-mediated perturbation of the immune-bone metabolism axis: a mechanistic investigation into bone loss in a simulated microgravity environment
Artificial Cells, Nanomedicine, and Biotechnology · Published 2025-10-23 · DOI 10.1080/21691401.2025.2576277
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1080/21691401.2025.2576277
Abstract
Spaceflight-related bone loss represents a critical health concern for astronauts undertaking prolonged space missions. This study investigated the mechanistic role of macrophage-derived exosomes in microgravity-induced bone loss using a simulated microgravity model. Phenotypic analysis of macrophages demonstrated that simulated microgravity promoted polarization towards the M2 phenotype and markedly suppressed the secretion of most pro-inflammatory cytokines. Exosomes were isolated and purified from macrophages cultured under normal gravity (1 g) and simulated microgravity (μg) conditions via ultracentrifugation. In vitro experiments revealed that exosomes from the μg group significantly inhibited the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and osteoblasts, without affecting cell migration. Subsequent in vivo studies involving tail-vein injection of exosomes into mice demonstrated a significant reduction in bone mass and impaired new bone formation in the μg group, exhibiting a distinct osteoporotic phenotype. Collectively, this study provides evidence at both cellular and animal levels that macrophage-derived exosomes play a role in microgravity-induced bone loss by inhibiting the proliferation and osteogenic differentiation of BMSCs and osteoblasts in a simulated microgravity environment. These findings offer a potential strategy for targeting the immune-bone metabolism axis to prevent spaceflight-associated osteoporosis.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- Mechanisms of pyroptosis in modulating osteoblast function under simulated microgravity · BMC Musculoskeletal Disorders · 2025 · Cites or is cited by this article
- Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Antimicrobial properties and bioactivity of zirconia-based biocomposites · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Human tendon stem/progenitor cell-derived extracellular vesicle production promoted by dynamic culture · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Identification of mitophagy-related biomarkers in human rheumatoid arthritis using machine learning models · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Multi-omics analysis of the potential association between ageing and rheumatoid arthritis and screening of potential therapeutic targets · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Cross-talk between diabetic nephropathy and bone loss: PBMCs-guided discovery of NLRP3-inflammatory signalling · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Bio-Inspired lipid nanovesicles (iNVs) incorporating membrane proteins from healthy tendon stem cells for targeted protein restoration in tendinopathic in vitro model · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal